Malignant Infratentorial Neoplasm — Trials

Malignant Infratentorial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

302 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 50
Ph III recruiting: 3
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06946680	IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)(Peds IMPACT)	not yet recruiting	Phase 1	24	University of FloridaOTHER	1	Sep 9, 2026	clinicaltrials
NCT07180927	DLL3 CAR-T Therapy Targeting Brain Tumors	not yet recruiting	Phase 1 / Phase 2	30	Shenzhen Geno-Immune Medical InstituteOTHER	1	Sep 1, 2026